Switching from semaglutide to tirzepatide often restarts the weight loss trajectory, presumably by engaging additional receptor pathways that monotherapy does not activate
Doses typically escalate gradually over weeks or months to help minimize any side effects
Tracking changes, following your prescribed plan, and recognising patterns can help reduce the likelihood of recurring digestive discomfort
- Tolerability profile consistent with the incretin class, with gastrointestinal events most commonly reported in studies (e.g., nausea, diarrhoea, and constipation)
GLP-1s are unlikely to deliver therapeutic value when so many individuals stop treatment after two years, but the findings also illustrate the need for obesity care management programs to improve adherence," David Lassen, chief clinical officer at Prime/MRx, said in a news release
Ipamorelin Benefits 1